<DOC>
	<DOC>NCT00648895</DOC>
	<brief_summary>The study is designed to compare the effects of nebivolol (10, 20, 40mg/day) with another beta blocker, extended-release metoprolol, at a range of doses. Its purpose is to study the mechanism of action of nebivolol on forearm blood flow, nitric oxide availability and other biomarkers.</brief_summary>
	<brief_title>A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Male or female, ambulatory outpatients 1879 years old at screening Minimum 2year history of Stage I/II hypertension Qualifying blood pressure criteria for study entry and for randomization Willing to adhere to the dietary compliance and undergo protocol procedures Have a lifestyle that will permit him/her to attend all evaluations, including those conducted on consecutive days Have any form of secondary hypertension Have clinically significant respiratory or cardiovascular disease Presence/history of coronary artery disease or peripheral vascular disease Have diabetes mellitus, Type I or II Have a history of hypersensitivity to nebivolol, metoprolol, or any betablocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>Bystolic (TM)</keyword>
	<keyword>Metoprolol ER (TM)</keyword>
</DOC>